Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
Daniel Victor Ortigoza, 2nd Vice President of the Cardio-Oncology Committee at the Argentine Federation of Cardiology and President of the Arrhythmias and Electrophysiology Committee of the Argentine Federation of Cardiology, shared a post on LinkedIn about a recent article by Tybjærg Nordestgaard et al, published in JAMA Cardiology:
”Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a). Ask Tybjærg Nordestgaard et al.
Lipoprotein(a) (LP(a) levels are known to be genetically determined, and elevated levels are (for now) an independent and unmodifiable risk factor for cardiovascular disease (CVD).
A 30-year prospective follow-up study was conducted in healthy women, primarily of European descent, comparing baseline LP(a) levels, clinical thresholds, LP(a) percentiles, and a specific genotype to establish the probability of developing CVD.
Figure 1. Restricted Cubic Spline Curves of 30-Year Hazard Ratios (HRs) for Major Cardiovascular Events (A), Coronary Heart Disease (B), Ischemic Stroke (C), and Cardiovascular Death (D)
- On the X-axis (baseline levels), analyze LP(a) levels; on the Y-axis, analyze HR (>1 => Risk). On the Y-axis, Graph A: HR for MACE, B: CHD, C: Stroke and D: Death.
- Color zone: Lp(a) levels, green: LP(a) < 10, blue < 30, etc.
- Vertical dotted lines indicating different percentiles.
- The gray band represents the HR width; the narrower the band, the greater the accuracy of the data.
- ight vertical line: Density percentage: referring to the LP (a) with respect to the total population under study.
Interpretation of the graph:
- In CVD the strongest associated risk is obtained with LP ( a) > 150mg/dl ( red) ( HR=2.5)
- In MACE the risk associated with LP ( a) > 100 mg/dl ( HR: 1.8)
- It carries moderate risks in stroke and cardiac death.
- Only women with Lp(a) levels > 30 mg/dl or above the 75th percentile were associated with major cardiovascular disease.”
Title: Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)
Authors: Tybjærg Nordestgaard, Daniel I. Chasman, Vinayaga Moorthy, Jordan M. Kraaijenhof, Nancy R. Cook, I-Min Lee, Julie E. Buring, Paul M. Ridker
Read the Full Article on JAMA Cardiology․

Stay updated on all scientific advances with Hemostasis Today.
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?